Re: Astrazeneca PLC - AZN
AZN Astrazeneca Plc The London health-care company said the U.S. FDA gave the go ahead to Teva Pharmaceutical to market a generic version of its Pulmicort asthma treatment. “AstraZeneca disagrees with several elements of the FDA's decision and is considering its options to respond,” the company said. 40.38 -1.59 / -3.79%
__________________
All my posts are purely my opinion. Please use your own buy and sell signals and never invest in a stock you can not afford to lose money on. For a complete disclaimer click here
|